腫瘍病理鑑別診断アトラス　骨腫瘍

出版社： 文光堂
著者：
発行日： 2016-05-03
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784830622496
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2016-05-03 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
発送目安：8～14営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

骨腫瘍の中でも高頻度のものを中心に，最新の診断基準に沿って，典型的な組織像を供覧し解説する．バリエーションの多い骨肉腫と軟骨肉腫では，亜型により全く悪性度が異なることも考慮し，多くの紙面を割いた．また，病理診断でよく遭遇する組織学的所見を呈する腫瘍[骨形成性腫瘍，軟骨形成性腫瘍，巨細胞の多く出現する腫瘍，小円形細胞腫瘍および上皮様の形態を呈する腫瘍]を系統的に解説．骨腫瘍の診断・治療を行う多くの医師必携の書．

目次

  • 表紙
  • 執筆者一覧
  • 序文
  • 目次
  • 第1部 検鏡前の確認事項
  • I. 骨腫瘍のWHO分類 : 分類の変遷と最新の分類の問題点
  • 1. 主な変更点
  • 2. 問題点
  • II. 骨腫瘍の頻度, 年齢, 発生部位
  • 1. 骨腫瘍の発生頻度
  • 2. 骨腫瘍の発生年齢
  • 3. 骨腫瘍の発生部位
  • III. 病理標本の取扱い方
  • 1. 術中迅速診断
  • 2. 生検検体
  • 3. 手術検体
  • 第2部 組織型と診断の実際
  • I. 軟骨形成性腫瘍
  • 1. 良性軟骨形成性腫瘍
  • 2. 中間性軟骨形成性腫瘍 : 軟骨芽細胞腫と軟骨粘液線維腫
  • 3. 通常型および二次性軟骨肉腫
  • 4. 特殊型軟骨肉腫
  • II. 骨形成性腫瘍
  • 1. 良性・中間性骨形成性腫瘍
  • 2. 通常型骨肉腫
  • 3. 特殊型骨肉腫
  • 4. 表在性骨肉腫
  • III. 線維性および線維組織球性腫瘍
  • 1. 類腱線維腫と非骨化性線維腫 / 骨幹端線維性欠損 / 良性線維性組織球腫
  • IV. 富破骨細胞性巨細胞腫瘍
  • 1. 指趾骨巨細胞性病変 / 巨細胞修復性肉芽腫
  • 2. 骨巨細胞腫
  • V. 脊索性腫瘍
  • 1. 良性脊索細胞腫と脊索腫
  • VI. 血管性腫瘍
  • 1. 血管腫 ( 良性 ) および類上皮血管腫 ( 中間性 )
  • 2. 類上皮血管内皮腫および血管肉腫
  • VII. 性状が不明確な腫瘍
  • 1. 単発性骨嚢腫
  • 2. 線維性異形成
  • 3. 骨線維性異形成
  • 4. 動脈瘤様骨嚢腫
  • 5. Langerhans細胞組織球症
  • VIII. 関節腫瘍
  • 1. 色素性絨毛結節性滑膜炎
  • 2. 滑膜軟骨腫症
  • 3. 滑膜脂肪腫
  • IX. その他の腫瘍
  • 1. Ewing肉腫
  • 2. アダマンチノーマ
  • 3. 骨未分化高悪性度多形肉腫
  • 第3部 鑑別ポイント
  • I. 骨肉腫との鑑別を要する骨形成性腫瘍
  • 1. 骨肉腫の亜型と特徴
  • 2. 髄内骨肉腫と表在性骨肉腫の関係
  • 3. 組織所見からみた骨肉腫の鑑別診断
  • II. 軟骨肉腫と鑑別を要する軟骨形成性腫瘍
  • 1. 軟骨芽細胞型骨肉腫
  • 2. 内軟骨腫
  • 3. 軟骨芽細胞腫
  • 4. 軟骨粘液線維腫
  • 5. 線維軟骨性異形成
  • 6. 滑膜軟骨腫症
  • 7. ピロリン酸カルシウム結晶沈着症
  • III. 巨細胞の出現する腫瘍の鑑別
  • 1. 臨床的事項
  • 2. 組織学的診断時の注意事項
  • 3. 鑑別を要するOCGCの出現する各疾患の組織学的特徴
  • IV. 骨小円形細胞腫瘍の鑑別診断
  • 1. Ewing肉腫とEwing様肉腫
  • 2. 小細胞骨肉腫とEwing肉腫
  • 3. 骨リンパ腫
  • 4. 形質細胞腫瘍
  • 5. 間葉性軟骨肉腫と骨肉腫
  • 6. 癌腫の転移
  • 7. そのほかの鑑別
  • V. 転移性骨腫瘍と上皮様骨腫瘍の鑑別
  • 1. 定義・概念
  • 2. 鑑別の要点
  • 3. 上皮様骨腫瘍の鑑別診断の実際
  • 第4部 臨床との連携
  • I. 骨腫瘍の外科治療
  • 1. 骨腫瘍に対する標準的外科治療
  • 2. 手術後の再建法
  • II. 悪性骨腫瘍の薬物療法および放射線療法
  • 1. 病期分類
  • 2. 薬物療法
  • 3. 放射線治療
  • 4. 医師主導臨床試験および治験
  • III. 免疫染色と遺伝子診断
  • 1. 骨形成性腫瘍
  • 2. 軟骨形成性腫瘍
  • 3. 小円形細胞腫瘍
  • 4. 富破骨細胞性巨細胞腫瘍
  • 5. その他
  • IV. 骨肉腫の組織学的効果判定と切除縁評価
  • 1. 骨肉腫の組織学的効果判定
  • 2. 切除縁評価
  • V. 病理診断報告書の記載
  • 1. 病理診断報告書の構成
  • 2. 病理診断
  • 3. 病理所見 ( コメント )
  • 索引
  • 奥付

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.4 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
3) Lichtenstein K : Classification of primary tumors of bone. Cancer 4 : 335-341, 1951
 
4) Fletcher CDM, Unni KK, Mertens F (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, 3rd ed, IARC Press, Lyon, 2002
 
5) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2016, pp181-196
 
P.9 掲載の参考文献
1) 日本整形外科学会骨軟部腫瘍委員会 : 平成25年度全国骨腫瘍登録一覧表, 国立がん研究センター, 2013, pp24-31
 
2) Grimer RJ, Hogendoorn PCW, Vanel D : Tumours of bone : Introduction. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp244-247
 
3) Unni KK, Inwards CY, Bridge JA, et al : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints, AFIP, Washington DC, 2005, pp1-10
 
4) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2015, pp1-30
 
5) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp12-18
 
6) 森岡秀夫 (編) : 概論 骨・軟部腫瘍診療のポイント. 整形外科専門医になるための診療スタンダード-4 骨・軟部腫瘍および骨系統・代謝性疾患, 羊土社, 2009, pp12-42
 
P.12 掲載の参考文献
1) Unni KK, Inwards CY, Bridge JA : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints, AFIP, Washington DC, 2005
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012
 
3) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2015
 
4) 福永真治 : 骨・軟部腫瘍. 病理と臨床 31 (臨増) : 352-359, 2013
 
5) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 

第2部 組織型と診断の実際

P.22 掲載の参考文献
1) Bovee JVMG, Heymann D, Wuyts W : Osteochondroma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp250-251
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp137-146
 
3) Endo M, Hasegawa T, Tashiro T, et al : Bizarre parosteal osteochondromatous proliferation with a t (1 ; 17) translocation. Virchows Arch 447 : 99-102, 2005
 
4) Feely MG, Boehm AK, Bridge RS, et al : Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma. Cancer Genet Cytogenet 137 : 102-107, 2002
PubMed
5) Jones KB, Piombo V, Searby C, et al : A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci U S A 107 : 2054-2059, 2010
PubMed
6) Matsumoto K, Irie F, Mackem S, et al : A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci U S A 107 : 10932-10937, 2010
PubMed
7) Lucas DR, Bridge JA : Chondromas : enchondroma, periosteal chondroma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp252-254
 
8) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp120-128
 
9) Hogendoorn PCW, Bovee JVMG, Nielsen GP : Chondrosarcoma (grade I-III), including primary and secondary variants and periosteal chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp264-268
 
10) Sakai Junior N, Abe KT, Formigli LM, et al : Cytogenetic findings in 14 benign cartilaginous neoplasms. Cancer Genet 204 : 180-186, 2011
PubMed
11) Dahlen A, Mertens F, Rydholm A, et al : Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 16 : 1132-1140, 2003
PubMed
12) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
13) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp128-132
 
P.28 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013, pp240-241, 255-256, 262-263
 
2) Bogdan C : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2015, pp246, 249-250, 400-438, 457
 
3) Jaffe HL, Lichtenstein L : Benign chondroblastoma of bone : a reinterpretation of the so-called calcifying or chondromatous giant cell tumor. Am J Pathol 18 : 969-991, 1942
PubMed
4) Jaf fe HL, Lichtenstein L : Chondromyxoid fibroma of bone ; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol 45 : 541-551, 1948
 
5) Weiss AP, Dorfman HD : S-100 protein in human cartilage lesions. J Bone Joint Surg Am 68 : 521-526, 1986
PubMed
6) Park HR, Park YK, Jang KT, et al : Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibroma. Oncol Rep 9 : 1087-1091, 2002
PubMed
7) Konishi E, Okubo T, Itoi M, et al : Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol 41 : 208-213, 2010
 
P.38 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) Unni KK, Inwards CY : Dahlin's Bone Tumors : General Aspects and Data on 10,165 Cases, 6th ed, Lippincott Williams & Wilkins, Philadelphia, 2010
 
3) Unni KK, Inwards CY, Bridge JA, et al : Tumors of the bones and joints. in Silverberg SG, Sobin LH (eds) : "AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints", AFIP, Washington DC, 2005
 
4) Bovee JVMG, Hogendoorn PCV, Wunder JS, et al : Cartilage tumours and bone development : molecular pathology and possible therapeutic targets. Nat Rev Cancer 10 : 481-488, 2010
 
5) Verdegaal SH, Bovee JV, Pansuriya TC, et al : Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome : an international multicenter study of 161 patients. Oncologist 16 : 1771-1779, 2011
PubMed
6) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
7) Konishi E, Nakashima Y, Mano M, et al : Primary central chondrosarcoma of long bone, limb girdle and trunk : analysis of 174 cases by numerical scoring on histology. Pathol Int 65 : 468-475, 2015
PubMed
8) Nojima T, Unni KK, MacLeod RA, et al : Periosteal chondroma and periosteal chondrosarcoma. Am J Surg Pathol 9 : 666-677, 1985
 
9) Murphey MD, Flemming DJ, Boyea SR, et al : Enchondroma versus chondrosarcoma in the appendicular skeleton : differentiating features. Radiographics 18 : 1213-1237, Quiz 1244-1245, 1998
 
10) Bernard SA, Murphey MD, Flemming DJ, et al : Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging. Radiology 255 : 857-865, 2010
 
11) Bjornsson J, McLeod RA, Unni KK, et al : Primary chondrosarcoma of long bones and limb girdles. Cancer 83 : 2105-2119, 1998
PubMed
12) Evans HL, Ayala AG, Romsdahl MM : Prognostic factors in chondrosarcoma of bone : a clinicopathologic analysis with emphasis on histologic grading. Cancer 40 : 818-831, 1977
 
13) Angelini A, Guerra G, Mavrogenis AF, et al : Clinical outcome of central conventional chondrosarcoma. J Surg Oncol 106 : 929-937, 2012
PubMed
14) Lee FY, Mankin HJ, Fondren G, et al : Chondrosarcoma of bone : an assessment of outcome. J Bone Joint Surg Am 81 : 326-338, 1999
 
15) Gelderblom H, Hogendoorn PC, Bloem JL, et al : The clinical approach towards chondrosarcoma. Oncologist 13 : 320-329, 2008
 
16) Eefting D, Schrage YM, Geirnaerdt MJ, et al : Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol 33 : 50-57, 2009
PubMed
17) Jones KB, Buckwalter JA, McCarthy EF, et al : Reliability of histopathologic and radiologic grading of cartilaginous tumors. J Bone Joint Surg Am 89 : 2113-2123, 2007
 
18) Mirra JM, Gold R, Downs J, et al : A few histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop Relat Res 201 : 214-237, 1985
 
19) Geirnaerdt MJA, Hermans J, Bloem JL, et al : Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. Am J Roentgenol 169 : 1097-1104, 1997
 
20) Jaffe HL : Tumors and Tumorous Conditions of the Bones and Joints, Lea and Febiger, Philadelphia, 1958
 
21) Dahlin DC, Salvador AH : Chondrosarcomas of bones of the hands and feet-a study of 30 cases. Cancer 34 : 755-760, 1974
 
22) Dahlin DC, Henderson ED : Chondrosarcoma, a surgical and pathological problem ; review of 212 cases. J Bone Joint Surg Am 38A : 1025-1038, 1956
 
23) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
24) Amary MF, Damato S, Halai D, et al : Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43 : 1262-1265, 2011
PubMed
25) Tarpey PS, Behjati S, Cooke SL, et al : Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet 45 : 923-926, 2013
PubMed
26) Tiet TD, Hopyan S, Nadesan P, et al : Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol 168 : 321-330, 2006
PubMed
27) Bridge JA, Nelson M, Orndal C, et al : Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer 82 : 1657-1663, 1998
PubMed
28) Hameetman L, Szuhai K, Yavas A, et al : The role of EXT1 in nonhereditary osteochondroma : identification of homozygous deletions. J Natl Cancer Inst 99 : 396-406, 2007
PubMed
29) de Andrea CE, Reijnders CM, Kroon HM, et al : Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT. Oncogene 31 : 1095-1104, 2012
PubMed
P.50 掲載の参考文献
1) Inwards C, Hogendoorn PCW : Dedifferentiated chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", IARC Press, Lyon, 2013, pp269-270
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp181-186
 
3) Littrell LA, Wenger DE, Wold LE, et al : Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas : a retrospective review of 174 de novo cases. Radiographics 24 : 1397-1409, 2004
 
4) Knosel T, Werner M, Jung A, et al : Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma? Pathol Res Pract 210 : 194-197, 2014
PubMed
5) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
6) Morrison C, Radmacher M, Mohammed N, et al : MYC amplification and polysomy 8 in chondrosarcoma : array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol 23 : 9369-9376, 2005
PubMed
7) Bovee JV, Cleton-Jansen AM, Rosenberg C, et al : Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189 : 454-462, 1999
PubMed
8) Bridge JA, DeBoer J, Travis J, et al : Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. Am J Pathol 144 : 215-220, 1994
PubMed
9) Nakashima Y, de Pinieux, Ladanyi M : Mesenchymal chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", IARC Press, Lyon, 2013, pp271-272
 
10) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp193-202
 
11) Frezza AM, Cesari M, Baumhoer D, et al : Mesenchymal chondrosarcoma : prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer 51 : 374-381, 2015
PubMed
12) Fanburg-Smith JC, Auerbach A, Marwaha JS, et al : Reappraisal of mesenchymal chondrosarcoma : novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Hum Pathol 41 : 653-662, 2010
PubMed
13) Wang L, Motoi T, Khanin R, et al : Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51 : 127-139, 2012
PubMed
14) Nakayama R, Miura Y, Ogino J, et al : Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma. Pathol Int 62 : 823-826, 2012
PubMed
15) McCarthy EF, Hogendoorn PCW : Clear cell chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", IARC Press, Lyon, 2013, pp273-274
 
16) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp186-193
 
17) Collins MS, Koyama T, Swee RG, et al : Clear cell chondrosarcoma : radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation. Skeletal Radiol 32 : 687-694, 2003
PubMed
18) Park YK, Cho CH, Chi SG, et al : Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma. Int J Oncol 19 : 749-753, 2001
 
19) Park YK, Park HR, Chi SG, et al : Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma. Int J Oncol 19 : 353-37l, 2001
 
20) Meijer D, de Jong D, Pansuriya TC, et al : Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes Cancer 51 : 899-909, 2012
PubMed
21) Matsuura S, Ishii T, Endo M, et al : Epithelial and cartilaginous differentiation in clear cell chondrosarcoma. Hum Pathol 44 : 237-243, 2013
PubMed
P.56 掲載の参考文献
1) Jaffe HL, Mayer L : An osteoblastic-osteoid tissue forming tumor of a metacarpal bone. Arch Surg 24 : 550-564, 1932
 
2) Jaffe H : "Osteoid osteoma" : a benign osteoblastic tumor composed of osteoid and atypical bone. Arch Surg 31 : 709-728, 1935
 
3) Jaffe HL : Benign osteoblastoma. Bull Hosp Joint Dis 17 : 141-151, 1956
PubMed
4) Lichtenstein L : Benign osteoblastoma : a category of osteoid- and bone-forming tumors other than classical osteoid osteoma, which may be mistaken for giant-cell-tumor or osteogenic sarcoma. Cancer 9 : 1044-1052, 1956
PubMed
5) Dorfman HD : Malignant transformation of benign bone lesions. Proc Natl Cancer Conf 7 : 901-903, 1972
PubMed
6) Wold LE, Pritchard DJ, Wilson DM, et al : Prostaglandin synthesis by osteoid osteoma and osteoblastoma. Mod Pathol 1 : 129-131, 1988
PubMed
7) Mungo DV, Zhang X, Schwarz EM, et al : COX-1 and COX-2 expression in osteoid osteoma. J Orthop Res 20 : 159-162, 2002
PubMed
8) Mirra JM, Kendrick RA, Kendric RE : Pseudomalignant osteoblastoma versus arrested osteosarcoma : a case report. Cancer 37 : 2005-2014, 1976
 
9) Schajowicz F, Lemos C : Malignant osteoblastoma. J Bone Joint Surg Br 58 : 202-211, 1976
PubMed
10) Dorfman HD, Weiss SW : Borderline osteoblastic tumors : problem in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1 : 215-234, 1984
PubMed
11) Lucas DR, Unni KK, Sim FH, et al : Osteoblastoma : clinicopathologic study of 306 cases. Hum Pathol 25 : 117-137, 1994
PubMed
12) Dorfman HD, Czerniak B : Benign osteoblastic tumor. in "Bone Tumors", Mosby, St Louis, 1998, pp85-127
 
P.64 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
3) Jaffe HL : Tumors and Tumorous Conditions of the Bones and Joints, Lea & Febiger, Philadelphia, 1958
 
4) Ackerman LV, Spjut HJ : Atlas of Tumor Pathology, 2nd Series, Fascicle 4, Tumors of Bone and Cartilage, AFIP, Washington DC, 1962
 
5) Spjut HT, Dorfman HD, Fechner RE, et al : Atlas of Tumor Pathology, 2nd Series, Fascicle 5, Tumors of Bone and Cartilage, AFIP, Washington DC, 1971
 
6) Lichtenstein L : Bone Tumors, 5th ed, Mosby, St Louis, 1977
 
7) Dahlin DC, Unni KK : Bone Tumors, General Aspects and Data on 8,542 Cases, 4th ed, Charles C Thomas, Springfield, 1986
 
8) Resnick D : Bone and Joint Imaging, 2nd ed, WB Saunders, Philadelphia, 1996
 
9) Enneking WF : Clinical Musculoskeletal Pathology, Storter Printing, Gainesville, 1970
 
10) 松野丈夫 : 骨腫瘍. 中村利孝他 (編) : 標準整形外科学, 第11版, 医学書院, 2011, pp331-360
 
11) 町並陸生, 牛込新一郎 : 取扱い規約に沿った腫瘍鑑別診断アトラス 骨, 文光堂, 東京, 1992
 
12) Hasegawa T, Shibata T, Hirose T, et al : Osteosarcoma with epithelioid features : an immunohistochemical study. Arch Pathol Lab Med 117 : 295-298,1993
PubMed
13) Bertoni F, Unni KK, McLeod RA, et al : Osteosarcoma resembling osteoblastoma. Cancer 55 : 416-426, 1985
PubMed
14) Dorfman HD, Weiss SW : Borderline osteoblastic tumors : problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1 : 215-234, 1984
PubMed
15) Aycan OE, Vanel D, Righi A, et al : Chondroblastoma-like osteosarcoma : a case report and review. Skeletal Radiol 44 : 869-873, 2015
PubMed
16) Toguchida J, Nakayama T : Molecular genetics of sarcomas : applications to diagnoses and therapy. Cancer Sci 100 : 1573-1580, 2009
PubMed
17) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distingushes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
18) Dujardin F, Binh MB, Bouvier C, et al : MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 24 : 624-637, 2011
PubMed
19) Yoshida A, Ushiku T, Moto T, et al : MDM2 and CDK4 immunohistochemical coexpression in high grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
 
P.75 掲載の参考文献
1) Matsuno T, Unni KK, McLeod RA, et al : Telangiectatic osteogenic sarcoma. Cancer 38 : 2538-2547, 1976
PubMed
2) Oliveira AM, Okada K, Squire J : Telangiectatic osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp289-290
 
3) Matsuno T, Okada K, Knuutila S : Telangiectatic osteosarcoma. in Fletcher CDM, Unni KK, Mertins F (eds) : "WHO Classification of Tumours, Pathology and Genetics Tumours of Soft Tissue and Bone", 3rd ed, IARC Press, Lyon, 2002, pp271-272
 
4) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp82-87
 
5) Martin JW, Squire JA, Zielenska M : The genetics of osteosarcoma. Sarcoma 2012 : 627254, 2012
PubMed
6) Sim FH, Unni KK, Beabout JW, et al : Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg 61A : 207-215, 1979
 
7) Ayala AG, Ro JY, Raymond AK, et al : Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer 64 : 2162-2173, 1989
PubMed
8) Forest M, De Pinieux G, Knuutila S : Secondary osteosarcoma. in Fletcher CDM, Unni KK, Mertins F (eds) : "WHO Classification of Tumours, Pathology and Genetics Tumours of Soft Tissue and Bone", 3rd ed, IARC Press, Lyon, 2002, pp277-278
 
9) Rosenberg AE, Cleton-Jansen AM, de Pinieux G, et al : Conventional osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp282-288
 
10) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp115-117
 
11) Deyrup AT, Montag AG, Inwards CY, et al : Sarcomas arising in Paget disease of bone : a clinicopathologic analysis of 70 cases. Arch Pathol Lab Med 131 : 942-946, 2007
PubMed
12) Unni KK, Dahlin DC, McLeod RA, et al : Intraosseous well-differentiated osteosarcoma. Cancer 40 : 1337-1347, 1977
PubMed
13) Inwards CY, Knuutila S : Low grade central osteosarcoma. in Fletcher CDM, Unni KK, Mertins F (eds) : "WHO Classification of Tumours, Pathology and Genetics Tumours of Soft Tissue and Bone", 3rd ed, IARC Press, Lyon, 2002, pp275-276
 
14) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
15) Yoshida A, Ushiku T, Motoi T, et al : MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
PubMed
16) Inwards CY, Squire J : Low-grade central osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp281-282
 
P.84 掲載の参考文献
1) Lazer A, Mertens F : Parosteal osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp292-293
 
2) Okada K, Frassica FJ, Sim, FH, et al : Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am 76 : 366-378, 1994
PubMed
3) Sheth DS, Yasko AW, Raymond AK, et al : Conventional and dedifferentiate parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer 78 : 2136-2145, 1996
 
4) Hang JF, Chen PC : Parosteal osteosarcoma. Arch Pathol Lab Med 138 : 694-699, 2014
PubMed
5) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
6) Dujardin F, Binh MB, Bouvier C, et al : MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 24 : 624-637, 2011
PubMed
7) Yoshida A, Ushiku T, Motoi T, et al : MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
PubMed
8) Montag AG, Squire J : Perioseal osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp294-295
 
9) Oda Y, Hashimoto H, Tsuneyoshi M, et al : Case report 793. Periosteal osteosarcoma of the clavicle. Skeletal Radiol 22 : 375-377, 1993
PubMed
10) Cesari M, Alberghini M, Vanel D, et al : Periosteal osteosarcoma : a single-institution experience. Cancer 117 : 1731-1735, 2011
PubMed
11) Righi A, Gambarotti M, Benini S, et al : MDM2 and CDK4 expression in periosteal osteosarcoma. Hum Pathol 46 : 549-553, 2015
PubMed
12) Radig K, Schneider-Stock R, Haeckel C, et al : p53 gene mutations in osteosarcomas of low-grade malignancy. Hum Pathol 29 : 1310-1316, 1998
PubMed
13) Wold LE, McCarthy EF, Squire J : High-grade surface osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp295-296
 
14) Yamaguchi H, Nojima T, Yagi T, et al : High-grade surface osteosarcoma of the left ilium. A case report and review of the literature. Acta Pathol Jpn 38 : 235-240, 1988
PubMed
15) Staals EL, Bacchini P, Bertoni F : High-grade surface osteosarcoma : a review of 25 cases from the Rizzoli Institute. Cancer 112 : 1592-1599, 2008
PubMed
16) Noble-Topham SE, Burrow SR, Eppert K, et al : SAS is amplified predominantly in surface osteosarcoma. J Orthop Res 14 : 700-705, 1996
PubMed
P.89 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Prees, Lyon, 2013, pp298, 302-304
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp238-249
 
3) Hauben EI, Jundt G, Cleton-Jansen AM, et al : Desmoplastic fibroma of bone : an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hum Pathol 36 : 1025-1030, 2005
PubMed
P.92 掲載の参考文献
1) Jaffe HL : Giant-cell reparative granuloma, traumatic bone cyst and fibrous (fibro-osseous) dysplasia of the jaw bones. Oral Surg Oral Med Oral Pathol 6 : 159-175, 1953
 
2) Ackerman LV, Spjut HJ : Giant cell reaction in tumors of bone and cartilage. in Spjut HJ, Dorfman HD, Fechner RE, et al (eds) : "Atlas for Tumor Pathology, Section II, Fascicle 4, 1st Series", AFIP, Washington, DC, 1962, p282
 
3) Lorenzo JC, Dorfman HD : Giant cell reparative granuloma of the short tubular bones of the hands and feet. Am J Surg Pathol 4 : 551-563, 1980
PubMed
4) Auclair PL, Cuenin P, Kratochvil FL, et al : A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor. Oral Surg Oral Med Oral Pathol 66 : 197-208, 1988
 
5) Forsyth R, Jundt G : Giant cell lesion of the small bones. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, p320
 
6) Robinson RA, Vincent SD : Central giant cell granuloma. in "AFIP Atlas of Tumor Pathology, Series 4, Fascicle 16, Tumors and Cysts of the Jaws", ARP Press, Silver Spring, 2012, pp183-187
 
7) 仙波伊知郎 : 中心性巨細胞病変. 森永正二郎, 高田隆, 長尾俊孝 (編) : 腫瘍病理鑑別診断アトラス頭頸部腫瘍 II, 文光堂, 2015, pp167-169
 
8) Agaram NP, LeLoarer FV, Zhang L : USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol 45 : 1147-1152, 2014
 
9) Johnson A, Collin A, Rydholm A : Unstable translocation (8 ; 22) in a case of giant cell reparative granuloma. Cancer Genet Cytogenet 177 ; 59-63, 2007
 
10) Struthers PJ, Shear M : Aneurysmal bone cyst of the jaws. Int J Oral Surg 13 : 92-100, 1984
PubMed
P.98 掲載の参考文献
1) Athanasou NA, Bansal M, Forsyth R, et al : Giant cell tumor of bone. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013
 
2) 日本整形外科学会骨軟部腫瘍委員会 (編) : 国立がんセンター全国骨腫瘍登録一覧表, 平成18年度-平成24年度
 
3) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier Saunders, Philadelphia, 2016, pp692-742
 
4) Fain JS, Unni KK, Beabout JW, et al : Nonepiphyseal giant cell tumor of the long bone. Cancer 71 : 3514-3519, 1993
 
5) Cleven AH, Hocker S, Briaire-de Bruijn l, et al : Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol 39 : 1576-1583, 2015
 
6) 小田義直 : 骨軟部腫瘍の悪性変化とその分子メカニズム. 福岡医学雑誌 102 : 1-7, 2011
 
7) Rock MG, Sim FH, Unni KK, et al : Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Joint Surg Am 68 : 1073-1079, 1986
PubMed
8) Gitelis S, Wang JW, Quast M, et al : Recurrence of giantcell tumor with malignant transformation to a fibrosarcoma twenty-five years after primary treatment. A case report. J Bone Joint Surg Am 71 : 757-761, 1989
 
9) Mori Y, Tsuchiya H, Karita M, et al : Malignant transformation of giant cell tumor 25 years after initial treatment. Clin Orthop Relat Res 381 : 185-191, 2000
PubMed
10) Machinami R, Nishida K, Ishida T, et al : Carcinosarcomatous malignancy, osteosarcoma and squamous cell carcinoma, in giant cell tumor of the right distal femur. Pathol Res Pract 204 : 583-588, 2008
PubMed
P.105 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) 山口岳彦 : 脊索病変の臨床病理. 病理と臨床 27 : 137-145, 2009
Medical*Online
3) 山口岳彦 : 良性脊索細胞腫. 脊椎脊髄ジャーナル 23 : 455-459, 2010
 
4) 山口岳彦 : 脊索病変. 病理と臨床 28 (臨増) : 352-353, 2010
 
5) 山口岳彦 : 良性脊索細胞腫. 青笹克之, 小田義直 (編) : 病理診断プラクティス 骨・軟部腫瘍, 中山書店, 2013, pp366-369
 
6) Yamaguchi T, Suzuki S, Ishiiwa H, et al : Intraosseous benign notochordal cell tumors : overlooked precursors of classic chordomas? Histopathology 44 : 597-602, 2004
PubMed
7) Yamaguchi T, Iwata J, Sugihara S, et al : Distinguishing benign notochordal cell tumor from vertebral chordoma. Skeletal Radiol 37 : 291-299, 2008
PubMed
8) Yamaguchi T, Yamato M, Saotome K : First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion : differential diagnosis of benign and malignant notochordal lesions. Skeletal Radiol 31 : 413-418, 2002
 
9) Deshpande V, Nielsen GP, Rosenthal DI, et al : Intraosseous benign notochord cell tumors (BNCT) : further evidence supporting a relationship to chordoma. Am J Surg Pathol 31 : 1573-1577, 2007
PubMed
10) Larousserie F, Drape JL, Chevrot A, et al : Case 32. International Skeletal Society Members' Meeting 2014
 
11) Ahmed SK, Murata H, Draf W : Clivus chordoma. Is it enough to image the primary site? Skull Base 20 : 111-113, 2010
PubMed
12) Yamaguchi T : On "clivus chordoma : is it enough to image the primary site?" (Skull Base 2010 ; 20 : 111-113). Skull Base 21 : 277-278, 2011
PubMed
13) Vujovic S, Henderson S, Presneau N, et al : Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209 : 157-165, 2006
PubMed
14) Matsubayashi J, Sato E, Nomura M, et al : A case of paravertebral mediastinal chordoma without bone destruction. Skeletal Radiol 41 : 1641-1644, 2012
 
15) Lalam R, Cassar-Pullicino VN, McClure J, et al : Entrapped intralesional marrow : a hitherto undescribed imaging feature of benign notochordal cell tumour. Skeletal Radiol 41 : 725-731, 2012
 
16) Tirabosco R, Mangham DC, Rosenberg AE, et al : Brachyury expression in extra-axial skeletal and soft tissue chordoma : a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 32 : 572-580, 2008
PubMed
17) Kikuchi Y, Yamaguchi T, Kishi H, et al : Pulmonary tumor with notochordal differentiation : report of two cases suggestive of benign notochordal cell tumor of extraosseous origin. Am J Surg Pathol 35 : 1158-1164, 2011
 
18) Takahashi Y, Motoi T, Harada M, et al : Extraosseous benign notochordal cell tumor originating in the lung : a case report. Medicine 94 : e366, 2015
 
P.108 掲載の参考文献
1) Hameed M, Wold LE : Haemangioma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, p332
 
2) 石田剛 : 骨脈管性腫瘍の臨床病理. 病理と臨床 27 : 156-168, 2009
Medical*Online
3) Rosenberg AE, Bovee JVMG : Epithelioid haemangioma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp333-334
 
4) O'Connell JX, Kattapuram SV, Mankin HJ, et al : Epithelioid hemangioma of bone. A tumor often mistaken for lowgrade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol 17 : 610-617, 1993
PubMed
5) Nielsen GP, Srivastava A, Kattapuram S, et al : Epithelioid hemangioma of bone revisited. A study of 50 cases. Am J Surg Pathol 33 : 270-277, 2009
PubMed
6) Evans HL, Raymond AK, Ayala AG : Vascular tumors of bone : a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol 34 : 680-689, 2003
 
P.114 掲載の参考文献
1) Rosenberg AE, Antonescu CR, Bovee JVMG : Epithelioid haemangioendothelioma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IRAC Press, Lyon, 2013
 
2) Weissferdt A, Moran CA : Epithelioid hemangioendothelioma of the bone : a review and update. Adv Anat Pathol 21 : 254-259, 2014
 
3) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid hemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
4) Mendlick MR, Nelson M, Pickering D, et al : Translocation t (1 ; 3) (p36.3 ; q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol 25 : 684-687, 2001
 
5) Honick JL, Fletcher CD : Pseudomyogenic hemangioendothelioma : a distinctive often multicentric tumor with indolent behavior. Am J Surg Pathol 35 : 190-201, 2011
 
6) Walther C, Tayebwa J, Lilljebjorn H, et al : A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol 232 : 534-540, 2014
PubMed
7) Lau K, Massad M, Pollack C, et al : Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement insights from an internet registry in the study of a rare cancer. Chest 140 : 1312-1318, 2011
 
8) Kleer CG, Unni KK, McLeod RA : Epithelioid hemangioendothelioma of bone. Am J Surg Pathol 20 : 1301-1311, 1996
PubMed
9) Bovee JVMG, Rosenberg AE : Angiosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IRAC Press, Lyon, 2013
 
10) Dunlap JB, Magenis RE, Davis C, et al : Cytogenetic analysis of a primary bone angiosarcoma. Cancer Genet Cytogenet 194 : 1-3, 2009
PubMed
11) Manner J, Radlwimmer B, Hohenberger P, et al : MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 176 : 34-39, 2010
PubMed
12) Verbeke SL, Bertoni F, Bacchini P, et al : Distinct histological features characterize primary angiosarcoma of bone. Histopathology 58 : 254-264, 2011
PubMed
P.117 掲載の参考文献
1) Miu A : Etiological aspects of solitary bone cysts : comments regarding the presence of the disease in two brothers. Is the genetic theory sustainable or is it pure coincidence? -Case report. J Med Life 8 : 509-512, 2015
PubMed
2) Kalil RK : Simple bone cyst. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp350-351
 
3) Aycan OE, Camurcu IY, Ozer D, et al : Unusual localizations of unicameral bone cysts and aneurysmal bone cysts : A retrospective review of 451 cases. Acta Orthop Belg 81 : 209-212, 2015
PubMed
4) Mascard E, Gomez-Brouchet A, Lambot K : Bone cysts : unicameral and aneurysmal bone cyst. Orthop Traumatol Surg Res 101 (1 Suppl) : S119-127, 2015
 
5) Takada J, Hoshi M, Oebisu N, et al : A comparative study of clinicopathological features between simple bone cysts of the calcaneus and the long bone. Foot Ankle Int 35 : 374-382, 2014
 
6) Doganavsargil B, Ayhan E, Argin M, et al : Cystic bone lesions : histopathological spectrum and diagnostic challenges. Turk Patoloji Derg 31 : 95-103, 2015
PubMed
P.121 掲載の参考文献
1) Vigorita VJ : Orthopaedic Pathology, 2nd ed, Lippincott Williams & Wilkins, Philadelphia, 2008, pp319-328
 
2) Ishida T, Dorfman HD : Massive chondroid differentiation in fibrous dysplasia of bone (fibrocartilaginous dysplasia). Am J Surg Pathol 17 : 924-930, 1993
PubMed
3) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp260-274
 
4) DiCaprio MR, Enneking WF : Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 87 : 1848-1864, 2005
PubMed
5) Siegal GP, Bianco P, Dal Cin P : Fibrous dysplasia. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp352-353
 
6) Weinstein LS, Shenker A, Gejman PV, et al : Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325 : 1688-1695, 1991
PubMed
7) Sakamoto A, Oda Y, Iwamoto Y, et al : A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsα mutation at the Arg201 codon : polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn 2 : 67-72, 2000
 
8) Ishida T, Iijima T, Kikuchi F, et al : A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 21 : 493-502, 1992
PubMed
9) Maki M, Saitoh K, Horiuchi H, et al : Comparative study of fibrous dysplasia and osteofibrous dysplasia : histopathological, immunohistochemical, argyrophilic nucleolar organizer region and DNA ploidy analysis. Pathol Int 51 : 603-611, 2001
PubMed
P.124 掲載の参考文献
1) Campanacci M : Osteofibrous dysplasia of long bones as a new clinical entity. Ital J Orthop Traumatol 2 : 221-237, 1976
PubMed
2) Vigorita VJ, Hogendoorn PCW, Sawyer JR : Osteofibrous dysplasia. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp354-355
 
3) Kempson RL : Ossifying fibroma of the long bones. A light and eloctron microscopic study. Arch Pathol 82 : 218-233, 1966
 
4) Unni KK, Inwards CY, Bridge JA, et al (eds) : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joint, AFIP, Washington DC, 2005
 
5) 石田剛 : 骨腫瘍の病理, 文光堂, 2012
 
6) Dorfman HD, Czerniak B : Bone Tumors, Mosby, St Louis, 1998
 
7) Campanacci M, Laus M : Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg Am 63 : 367-375, 1981
PubMed
8) Nakashima Y, Yamamuro T, Fujiwara Y, et al : Osteofibrous dysplasia (ossifying fibroma of long bones). A study of 12 cases. Cancer 52 : 909-914, 1983
 
P.127 掲載の参考文献
1) Jaffe HL : Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 6 : 159-175, 1953
 
2) Lorenzo JC, Dorfman HD : Giant-cell reparative granuloma of short tubular bones of the hands and feet. Am J Surg Pathol 4 : 551-563, 1980
PubMed
3) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
4) Sanerkin NG, Mott MG, Roylance J : An unusual intraosseous lesion with fibroblastic, osteoblastic, aneurysmal and fibromyxoid elements : "solid" variant of aneurysmal bone cyst. Cancer 51 : 2278-2286, 1983
PubMed
5) Oliveira AM, Perez-Atayde AR, Inwards CY, et al : USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165 : 1773-1780, 2004
PubMed
6) Erickson-Johnson MR, Chou MM, Evers BR, et al : Nodular fasciitis : a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest 91 : 1427-1433, 2011
PubMed
P.130 掲載の参考文献
1) Lichtenstein L : Histiocytosis X (eosinophilic granuloma of bone, Letterer-Siwe disease, and Schueller-Christian disease). Further observations of pathological and clinical importance. J Bone Joint Surg Am 46 : 76-90, 1964
PubMed
2) Unni KK, Inwards CY : Langerhans histiocytosis (histiocytosis X, eosinophilic granuloma). in "Dahlin's Bone Tumors", 6th ed, Lippincott Williams & Wilkins, Philadelphia, 2010, pp358-361
 
3) De Young B, Egeler RM, Rollins BJ : Langerhans cell histiocytosis. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp356-357
 
4) Willman CL, Busque L, Griffith BB, et al : Langerhans' -cell histiocytosis (histiocytosis X) -a clonal proliferative disease. N Engl J Med 331 : 154-160, 1994
PubMed
5) Yu RC, Chu C, Buluwela L, et al : Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 343 : 767-768, 1994
PubMed
6) Badalian-Very G, Vergilio JA, Degar BA, et al : Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol 156 : 163-172, 2012
PubMed
7) Brown NA, Furtado LV, Betz BL, et al : High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124 : 1655-1658, 2014
PubMed
P.135 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) Goldblum JR, Folpe AL, Weiss SW : Enzinger and Weiss's Soft Tissue Tumors, 6th ed, Elsevier Saunders, Philadelphia, 2014
 
3) Vigorita VJ : Orthopaedic Pathology, 2nd ed, Wolters Kluwer, Philadelphia, 2008
 
4) 江原茂 : 骨関節のX線診断, 金原出版, 1995
 
5) Hornick JL : Practical Soft Tissue Pathology : A Diagnostic Approach, Elsevier Saunders, Philadelphia, 2013
 
6) Oda Y, Izumi T, Harimaya K, et al : Pigmented villonodular synovitis with chondroid metaplasia, resembling chondroblastoma of the bone. A report of three cases. Mod Pathol 20 : 545-551, 2007
 
7) Fisher M, Biddinger P, Folpe AL, et al : Chondroid tenosynovial giant cell tumor of the temporal bone. Otol Neurotol 34 : c49-c50, 2013
 
8) Boland JM, Folpe AL, Hornick JL, et al : Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types. Diagnostic and histogenetic implications. Am J Surg Pathol 33 : 1225-1229, 2009
PubMed
9) Grogg KL, Lae ME, Kurtin PJ, et al : Clusterin expression distinguishes follicular dendritic cells tumors from other dendritic cell neoplasms. Report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritis cell tumors. Am J Surg Pathol 28 : 988-998, 2004
 
P.139 掲載の参考文献
1) Sciot R, Bridge JA : Synovial chondromatosis. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, p261
 
2) Nishimura K, Solchaga LA, Caplan AI, et al : Chondroprogenitor cells of synovial tissue. Arthritis Rheum 42 : 2631-2637, 1999
PubMed
3) Davis RI, Hamilton A, Biggart JD : Primary synovial chondromatosis : a clinicopathologic review and assessment of malignant potential. Hum Pathol 29 : 683-688, 1998
PubMed
4) Fetsch JF, Vinh TN, Remotti F, et al : Tenosynovial (extraarticular) chondromatosis : an analysis of 37 cases of an underrecognized clinicopathologic entity with a strong predilection for the hands and feet and a high local recurrence rate. Am J Surg Pathol 27 : 1260-1268, 2003
 
5) Milgram JW : Synovial osteochondromatosis : a histopathological study of thirty cases. J Bone Joint Surg Am 59 : 792-801, 1977
 
6) 石田剛, 今村哲夫 : 非腫瘍性骨関節疾患の病理, 文光堂, 2003, pp54-61
 
7) Buddingh EP, Krallman P, Neff JR, et al : Chromosome 6 abnormalities are recurrent in synovial chondromatosis. Cancer Genet Cytogenet 140 : 18-22, 2003
PubMed
8) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
9) Damato S, Alorjani M, Bonar F, et al : IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas. Histopathology 60 : 363-365, 2012
 
10) de Sa D, Horner NS, MacDonald A, et al : Arthroscopic surgery for synovial chondromatosis of the hip : a systematic review of rates and predisposing factors for recurrence. Arthroscopy 30 : 1499-1504, 2014
PubMed
11) Sah AP, Geller DS, Mankin HJ, et al : Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case report. J Bone Joint Surg Am 89 : 1321-1328, 2007
PubMed
12) O'Connell JX : Pathology of the synovium. Am J Clin Pathol 114 : 773-784, 2000
 
13) Bertoni F, Unni KK, Beabout JW, et al : Chondrosarcomas of the synovium. Cancer 67 : 155-162, 1991
PubMed
P.142 掲載の参考文献
1) Sanamandra S, Ong KO : Lipoma arborescens. Singapore Med J 55 : 5-11, 2014
PubMed
2) Bejia I, Younes M, Moussa A, et al : Lipoma arborescens affecting multiple joints. Skeletal Radiol 34 : 536-538, 2005
PubMed
3) Natera L, Gelber PE, Erquicia JI, et al : Primary lipoma arborescens of the knee may involve the development of early osteoarthritis if prompt synovectomy is not performed. J Orthopaed Traumatol 16 : 47-53, 2015
PubMed
P.150 掲載の参考文献
1) Antonescu C : Round cell sarcomas beyond Ewing : emerging entities. Histopathology 64 : 26-37, 2014
PubMed
2) Lucke A : Lympho-Sarcom der Achseldrusen ; embolische Geschwulste der Lungen ; allgemeine Leukamie. Tod. Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin (Virchow's Archiv) 35 : 524-530, 1866
 
3) Machinami R : Small round cell tumours of bone. Virchows Arch A Pathol Anat Histopathol 418 : 475-478, 1991
PubMed
4) Fletcher CDM, Bridge JA, Hogendoorn PCM, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
5) Tanaka M, Yamazaki Y, Kanno Y, et al : Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors. J Clin Invest 124 : 3061-3074, 2014
 
6) DeLaney TF, Hornicek FJ, Lessnick SL, et al : Epidemiology, pathology, and molecular genetics of the Ewing sarcoma family of tumors : Wolters Kluwer ; 2015 [cited (last updated : Dec 16, 2014)]. Available from : http://www.uptodate.com/contents/epidemiology-pathology-andmolecular-genetics-of-the-ewing-sarcoma-family-oftumors.
 
7) 植野映子, 松本誠一, 真鍋淳, 他 : [特徴的な局所進展を示す悪性腫瘍-small round cell tumorの画像診断] 骨軟部. 臨床画像 26 : 15-25, 2010
 
8) Kransdorf MJ, Murphy MD : Imaging of Soft Tissue Tumors, 3rd ed, Lipppincott Williams & Wilkins, Philadelphia, 2014
 
9) Yoshida A, Sekine S, Tsuta K, et al : NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36 : 993-999, 2012
PubMed
10) Bridge RS, Rajaram V, Dehner LP, et al : Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue : a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol 19 : 1-8, 2006
 
P.153 掲載の参考文献
1) Jain D, Jain VK, Vasishta RK, et al : Adamantinoma : a clinicopathological review and update. Diagn Pathol : 3 : 8, 2008
PubMed
2) Bridge JA, Fidler ME, Neff JR, et al : Adamantinoma-like Ewing's sarcoma : genomic confirmation, phenotypic drift. Am J Surg Pathol 23 : 159-165, 1999
 
3) Kikuchi Y, Kishimoto T, Ota S, et al : Adamantinoma-like Ewing family tumor of soft tissue associated with the vagus nerve : a case report and review of literature. Am J Surg Pathol 37 : 772-779, 2013
PubMed
4) 町並陸生 : 骨アダマンチノーマの病理, 特に骨線維性異形成との関連に注目して. 病理と臨床 10 : 1374-1384, 1992
 
5) Unni KK, Inwards CY, Bridge JA, et al : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints, AFIP, Washington DC, 2005 pp299-307
 
6) Gleason BC, Liegl-Atzwanger B, Kozakewich HP, et al : Osteofibrous dysplasia and adamantinoma in children and adolescents : a clinicopathologic reappraisal. Am J Surg Pathol 32 : 363-376, 2008
PubMed
P.158 掲載の参考文献
1) Romeo S, Bovee JVMG, Jundt G : Undifferentiated highgrade pleomorphic sarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp364-365
 
2) Unni KK, Inwards CY : Dahlin's Bone Tumors, 3rd ed, Lippincott Williams & Wilkins, Philadelphia, 2010, pp184-190
 
3) Martignetti JA, Gelb BD, Pierce H, et al : Malignant fibrous histiocytoma : inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22-evidence for a common genetic defect. Genes Chromosomes Cancer 27 : 191-195, 2000
PubMed
4) Tarkkanen M, Larramendy ML, Bohling T, et al : Malignant fibrous histiocytoma of bone : analysis of genomic imbalances by comparative genomic hybridisation and CMYC expression by immunohistochemistry. Eur J Cancer 42 : 1172-1180, 2006
 
5) Horvai AE, Roy R, Borys D, et al : Regulators of skeletal development : a cluster analysis of 206 bone tumors reveals diagnostically useful markers. Mod Pathol 25 : 1452-1461, 2012
PubMed
6) Conner JR, Hornick JL : SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 63 : 36-49, 2013
PubMed
7) Bielack SS, Schroeders A, Fuchs N, et al : Malignant fibrous histiocytoma of bone : a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand 70 : 353-360, 1999
 
8) Campanacci M : Malignant fibrous histiocytoma. in "Bone and Soft Tissue Tumors : Clinical Features, Imaging, Pathology and Treatment", Piccin Nuova Libraria, Padova, 1999, pp161-173
 

第3部 鑑別ポイント

P.168 掲載の参考文献
1) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp55-118
 
2) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
3) Yalcinkaya U, Doganavsargil B, Sezak M, et al : Clinical and morphological characteristics of osteoid osteoma and osteoblastoma : a retrospective single-center analysis of 204 patients. Ann Diagn Pathol 18 : 319-325, 2014
PubMed
4) Dorfman HD, Weiss SW : Borderline osteoblastic tumors : problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1 : 215-234, 1984
PubMed
5) 石田剛, 今村哲夫 : 非腫瘍性骨関節疾患の病理, 文光堂, 2003, pp177-201
 
6) Spjut HJ, Dorfman HD : Florid reactive periostitis of the tubular bones of the hands and feet. A benign lesion which may simulate osteosarcoma. Am J Surg Pathol 5 : 423-433, 1981
 
7) Tabareau-Delalande F, Collin C, Gomez-Brouchet A, et al : Diagnostic value of investigating GNAS mutations in fibro-osseous lesions : a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod Pathol 26 : 911-921, 2013
PubMed
8) Nora FE, Dahlin DC, Beabout JW : Bizarre parosteal osteochondromatous proliferations of the hands and feet. Am J Surg Pathol 7 : 245-250, 1983
PubMed
9) Nilsson M, Domanski HA, Mertens F, et al : Molecular cytogenetic characterization of recurrent translocation breakpoints in bizarre parosteal osteochondromatous proliferation (Nora's lesion). Hum Pathol 35 : 1063-1069, 2004
 
P.173 掲載の参考文献
1) Kerr DA, Lopez HU, Deshpande V, et al : Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations. Am J Surg Pathol 37 : 787-795, 2013
PubMed
2) Pansuriya TC, van Eijk R, d'Adamo P, et al : Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 43 : 1256-1261, 2011
 
3) Bianco P, Riminucci M, Majolagbe A, et al : Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15 : 120-128, 2000
PubMed
P.182 掲載の参考文献
1) Monda L, Wick MR : S-100 protein immunostaining in the differential diagnosis of chondroblastoma. Hum Pathol 16 : 287-293, 1985
PubMed
2) Behjati S, Tarpey PS, Presneau N, et al : Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45 : 1479-1482, 2013
PubMed
3) Presneau N, Baumhoer D, Behjati S, et al : Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res 1 : 113-123, 2015
PubMed
4) Cleven AH, Hocker S, Briaire-de Bruijn I, et al : Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol 39 : 1576-1583, 2015
PubMed
5) Oliveira AM, Hsi BL, Weremowicz S, et al : USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 64 : 1920-1923, 2004
PubMed
6) Oliveira AM, Perez-Atayde AR, Inwards CY, et al : USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165 : 1773-1780, 2004
PubMed
7) Agaram NP, LeLoarer FV, Zhang L, et al : USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol 45 : 1147-1152, 2014
 
8) Wang CS, Yin QH, Liao JS, et al : Giant cell-rich osteosarcoma in long bones : clinical, radiological and pathological features. Radiol Med 118 : 1324-1334, 2013
PubMed
9) Nagata S, Nishimura H, Uchida M, et al : Giant cell-rich osteosarcoma of the distal femur : radiographic and magnetic resonance imaging findings. Radiat Med 24 : 228-232, 2006
PubMed
10) Chow LT : Fibular giant cell-rich osteosarcoma virtually indistinguishable radiographically and histopathologically from giant cell tumor-analysis of subtle differentiating features. APMIS 123 : 530-539, 2015
PubMed
P.191 掲載の参考文献
1) Shibuya R, Matsuyama A, Nakamoto M, et al : The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 : 599-605, 2014
 
2) Yoshida A, Sekine S, Tsuta K, et al : NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36 : 993-999, 2012
PubMed
3) Specht K, Sung YS, Zhang L, et al : Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas : further evidence toward distinct pathologic entities. Genes Chromosomes Cancer 53 : 622-633, 2014
PubMed
4) Sugita S, Arai Y, Tonooka A, et al : A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma : a genetically distinct variant of Ewing-like sarcoma. Am J Surg Pathol 38 : 1571-1576, 2014
PubMed
5) Yoshida A, Goto K, Kodaira M, et al : CIC-rearranged sarcomas : a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol 40 : 313-323, 2016
PubMed
6) Kawamura-Saito M, Yamazaki Y, Kaneko K, et al : Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t (4 ; 19) (q35 ; q13) translocation. Hum Mol Genet 15 : 2125-2137, 2006
 
7) Peters TL, Kumar V, Polikepahad S, et al : BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol 28 : 575-586, 2015
PubMed
8) Pierron G, Tirode F, Lucchesi C, et al : A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 44 : 461-466, 2012
 
9) Puls F, Niblett A, Marland G, et al : BCOR-CCNB3 (Ewing-like) sarcoma : a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Am J Surg Pathol 38 : 1307-1318, 2014
PubMed
10) Shibayama T, Okamoto T, Nakashima Y, et al : Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3 : a clinicopathological report of three pediatric cases. Pathol Int 65 : 410-414, 2015
PubMed
11) Nakajima H, Sim FH, Bond JR, et al : Small cell osteosarcoma of bone. Review of 72 cases. Cancer 79 : 2095-2106, 1997
PubMed
12) Righi A, Gambarotti M, Longo S, et al : Small cell osteosarcoma : clinicopathologic, immunohistochemical, and molecular analysis of 36 cases. Am J Surg Pathol 39 : 691-699, 2015
PubMed
13) Sim FH, Unni KK, Beabout JW, et al : Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg Am 61 : 207-215, 1979
 
14) Machado I, Alberghini M, Giner F, et al : Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases. Histopathology 57 : 162-167, 2010
PubMed
15) Debelenko LV, McGregor LM, Shivakumar BR, et al : A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma. Genes Chromosomes Cancer 50 : 1054-1062, 2011
 
16) Wojcik JB, Bellizzi AM, Dal Cin P, et al : Primary sclerosing epithelioid fibrosarcoma of bone : analysis of a series. Am J Surg Pathol 38 : 1538-1544, 2014
PubMed
17) Maruyama D, Watanabe T, Beppu Y, et al : Primary bone lymphoma : a new and detailed characterization of 28 patients in a single-institution study. Jpn J Clin Oncol 37 : 216-223, 2007
 
18) Nagasaka T, Nakamura S, Medeiros LJ, et al : Anaplastic large cell lymphomas presented as bone lesions : a clinicopathologic study of six cases and review of the literature. Mod Pathol 13 : 1143-1149, 2000
PubMed
19) Ozdemirli M, Fanburg-Smith JC, Hartmann DP, et al : Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma : a report of four cases and review of the literature. Am J Surg Pathol 22 : 795-804, 1998
 
20) Lin O, Filippa DA, Teruya-Feldstein J : Immunohistochemical evaluation of FLI-1 in acute lymphoblastic lymphoma (ALL) : a potential diagnostic pitfall. Appl Immunohistochem Mol Morphol 17 : 409-412, 2009
PubMed
21) Meis JM, Butler JJ, Osborne BM, et al : Granulocytic sarcoma in nonleukemic patients. Cancer 58 : 2697-2709, 1986
PubMed
22) Nakashima Y, Unni KK, Shives TC, et al : Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 57 : 2444-2453, 1986
PubMed
23) Wehrli BM, Huang W, De Crombrugghe B, et al : Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 34 : 263-269, 2003
PubMed
24) Wang L, Motoi T, Khanin R, et al : Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51 : 127-139, 2012
PubMed
25) Bishop JA, Alaggio R, Zhang L, et al : Adamantinoma-like Ewing family tumors of the head and neck : a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol 39 : 1267-1274, 2015
PubMed
P.198 掲載の参考文献
1) Kurzawa P, Kattapuram S, Hornicek FJ, et al : Primary myoepithelioma of bone : a report of 8 cases. Am J Surg Pathol 37 : 960-968, 2013
 
2) Vujovic S, Henderson S, Presneau N, et al : Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209 : 157-165, 2006
PubMed
3) Miettinen M, Wang Z, Lasota J, et al : Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas : an immunohistochemical study of 5229 cases. Am J Surg Pathol 39 : 1305-1312, 2015
PubMed
4) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
5) Doyle LA, Fletcher CD, Hornick JL : Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. Am J Surg Pathol 40 : 94-102, 2016
PubMed
6) Yoshida A, Sekine S, Tsuta K, et al : NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36 : 993-999, 2012
PubMed
7) Shibuya R, Matsuyama A, Nakamoto M, et al : The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 : 599-605, 2014
 

第4部 臨床との連携

P.203 掲載の参考文献
1) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015, pp42-51
 
2) 竹山信成, 桧垣昇三, 三輪隆他 : 膝周辺の骨巨細胞腫の治療-準切除術について. 臨床整形外科 20 : 851-857, 1985
 
3) Malawer MM, Bickels J, Meller I, et al : Cryosurgery in the treatment of giant cell tumor. A long-term follow up study. Clin Orthop Relat Res 359 : 176-188, 1999
PubMed
4) Kawaguchi N, Matumoto S, Manabe J : New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma : analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 121 : 555-563, 1995
 
5) Weber MA, Sprengel SD, Omlor GW, et al : Clinical longterm outcome, technical success, and cost analysis of radiofrequency ablation for the treatment of osteoblastomas and spinal osteoid osteomas in comparison to open surgical resection. Skeletal Radiol 44 : 981-993, 2015
 
6) Gaston CL, Bhumbra R, Watanuki M, et al : Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br 93 : 1665-1669, 2011
 
7) Manabe J, Ahmed AR, Kawaguchi N, et al : Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419 : 258-266, 2004
 
8) Sugiura H, Takahashi M, Nakanishi K, et al : Pasteurized intercalary autogenous bone graft combined with vascularized fibula. Clin Orthop Relat Res 456 : 196-202, 2007
PubMed
P.208 掲載の参考文献
1) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015, pp35, 36, 60
 
2) Iwamoto Y, Tanaka K, Isu K, et al : Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan : NECO-93J and NECO-95J. J Orthop Sci 14 : 397-404, 2009
PubMed
3) Iwamoto Y, Tanaka K : The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group. Jpn J Clin Oncol 42 : 467-470, 2012
 
4) Womer RB, West DC, Krailo MD, et al : Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma : a report from the Children's Oncology Group. J Clin Oncol 30 : 4148-4154, 2012
 
5) Kawaguchi S, Sun T, Lin PP, et al : Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma? Clin Orthop Relat Res 472 : 983-989, 2014
PubMed
6) Italiano A, Mir O, Cioffi A, et al : Advanced chondrosarcomas : role of chemotherapy and survival. Ann Oncol 24 : 2916-2922, 2013
PubMed
7) Dickey ID, Rose PS, Fuchs B, et al : Dedifferentiated chondrosarcoma : the role of chemotherapy with updated outcomes. J Bone Joint Surg Am 86-A : 2412-2418, 2004
PubMed
8) Cesari M, Bertoni F, Bacchini P, et al : Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori 93 : 423-427, 2007
 
9) Imai R, Kamada T, Sugahara S, et al : Carbon ion radiotherapy for sacral chordoma. Br J Radiol 84 : S48-54, 2011
PubMed
P.213 掲載の参考文献
1) Puls F, Niblett AJ, Mangham DC : Molecular pathology of bone tumours : diagnostic implications. Histopathology 64 : 461-476, 2014
PubMed
2) Horvai AE, Roy R, Borys D, et al : Regulators of skeletal development : a cluster analysis of 206 bone tumors reveals diagnostically useful markers. Mod Pathol 25 : 1452-1461, 2012
PubMed
3) Conner JR, Hornick JL : SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 63 : 36-49, 2013
PubMed
4) Hosono A, Yamaguchi U, Makimoto A, et al : Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. J Clin Pathol 60 : 410-414, 2007
PubMed
5) Wan Y, Zhao W, Jiang Y, et al : β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma. Hum Pathol 45 : 1459-1465, 2014
 
6) Yoshida A, Ushiku T, Motoi T, et al : MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
PubMed
7) Konishi E, Nakashima Y, Iwasa Y, et al : Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol 41 : 208-213, 2010
PubMed
8) Szuhai K, Cleton-Jansen A-M, Hogendoorn PCW, et al : Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 205 : 193-204, 2012
 
9) Shibuya R, Matsuyama A, Nakamoto M, et al : The combination of CD99 and NKX2.2, a transcription target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 : 599-605, 2014
 
10) Peters TL, Kumar V, Polikepahad S, et al : BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol 28 : 575-586, 2015
PubMed
11) Behjati S, Tarpey PS, Presneau N, et al : Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45 : 1479-1482, 2014
 
12) Oliveira AM, Chou MM : USP6-induced neoplasms : the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 45 : 1-11, 2014
PubMed
13) Roden AC, Hu X, Kip S, et al : BRAF V600E expression in Langerhans cell histiocytosis. Clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38 : 548-551, 2014
PubMed
14) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid hemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
15) Antonescu CR, Le Loarer F, Mosquera JM, et al : Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 52 : 775-784, 2013
PubMed
16) Athanasou NA, Quinn J, Heryet A, et al : Effect of decalcification agents on immunoreactivity of cellular antigens. J Clin Pathol 40 : 874-878, 1987
PubMed
17) Bussolati G, Leonardo E : Technical pitfalls potentially affecting diagnoses in immunohistochemistry. J Clin Pathol 61 : 1184-1192, 2008
PubMed
P.220 掲載の参考文献
1) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
2) 落合淳志 : 癌の治療効果と病理組織診断, 各種治療後の病理組織診断 (総論). 病理と臨床 26 : 440-446, 2008
 
3) Ayala AG, Raymond AK, Jaffe R : The pathologist's role in the diagnosis and treatment of osteosarcoma in children. Hum Pathol 15 : 258-266, 1984
 
4) Picci P, Bacci G, Campanaci M, et al : Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viab1e and non-viab1e tumor. Cancer 56 : 1515-1521, 1985
 
5) 平賀博明 : 骨肉腫に対する化学療法の最前線. 整形外科 61 : 809-814, 2010
 
6) 蛭田啓之, 町並陸生, 神田浩明, 他 : 骨肉腫の術前化学療法組織学的効果判断と問題点. 日本整形外科学会雑誌 84 : 1120-1125, 2010
 
7) 日本整形外科学会 骨・軟部腫瘍委員会 (編) : 骨・軟部肉腫切除縁評価法, 金原出版, 1989
 
8) Kawaguchi N, Matumoto S, Manabe J : New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 121 : 555-563, 1995
 
9) Kawaguchi N, Ahmed AR, Matsumoto S, et al : The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop 419 : 165-172, 2004
 
10) 阿江啓介, 松本誠一, 下地尚, 他 : 切除縁評価法の改正にむけて-バリア概念の検証. 日本整形外科学会雑誌 86 : 567-574, 2014
 
11) 阿江啓介, 松本誠一 : 肉腫外科治療の最前線 : 切除縁-ユニークな切除縁評価法と, 根拠に基づく安全な手術計画. 医学のあゆみ 254 : 285-290, 2015
Medical*Online
P.224 掲載の参考文献
1) 三上芳喜 : 病理組織・細胞診断報告書の読み方. 笹野公伸, 森谷卓也, 真鍋俊明 (編) : 臨床医・初期研究医のための病理検査室利用ガイド, 文光堂, 2004, pp83-111
 
2) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
3) Laster S : Soft-tissue tumors (sarcomas). in "Manual of Surgical Pathology", Churchill Livingstone, Philadelphia, 2001, pp116-128
 
4) Rubin BP, Antonescu CR, Gannon FH, et al : Protocol for the examination of specimens from patients with tumors of bone. Arch Pathol Lab Med 134 : e1-e7, 2010
PubMed
5) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013, pp246-247
 
6) Fleming ID, Cooper JS, Henson DE, et al (eds) : American Joint Committee on Cancer, Manual for Staging of Cancer, 5th ed, JB Lippincott, Philadelphia, 1997
 

書評

最近チェックした商品履歴

Loading...